Vertiseit: FX hurting in 2025 – Solid otherwise - Redeye
Redeye retains its positive view of Vertiseit following a Q1 report where FX and a higher headcount than expected hurt margins in Q1 and 2025. However, the important FX-adjusted organic ARR growth was strong, and the outlook is promising.
ANNONS
Redeye retains its positive view of Vertiseit following a Q1 report where FX and a higher headcount than expected hurt margins in Q1 and 2025. However, the important FX-adjusted organic ARR growth was strong, and the outlook is promising.